Royalty Pharma
RPRX
#1190
Rank
A$23.96 B
Marketcap
$40.67
Share price
1.28%
Change (1 day)
-0.86%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of September 2024 : A$2.70 Billion

According to Royalty Pharma's latest financial reports the company has A$2.70 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.81 B-49.24%
2022-12-31A$3.56 B-7.73%
2021-12-31A$3.86 B12.23%
2020-12-31A$3.44 B204.1%
2019-12-31A$1.13 B-66.55%
2018-12-31A$3.38 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.37 B-86.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.92 B 341.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.38 B 99.42%๐Ÿ‡บ๐Ÿ‡ธ USA